Condition: Endophthalmitis · Sponsor: Medical University of Graz
In this pilot study, the feasibility of the Oxford Nanopore MinION to identify pathogens from vitrectomy samples in eyes with endophthalmitis shall be assessed. The MinION is a low cost commercially available device for DNA/ RNA analysis that, in studies, has been used for pathogen determination in various infectious diseases as well as for the genetic characterization of hematologic tumors.
This description comes directly from the study's public registry record.
Michael Sommer, MD · 004331638531033 · michael.sommer@medunigraz.at
Gerald Seidel, MD, PhD · 004331638580714 · gerald.seidel@medunigraz.at
Always discuss trial participation with your own doctor first.
| Universitäts Augenklinik Graz | Graz, Styria, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05372861